Clinical characteristics and prognosis analysis of patients with de novo ASXL1‐mutated AML treated with the C‐HUNAN‐AML‐15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group - Zeng, Minhui; Chen, Keke; Tian, Xin; Zou, Runying; Feng, Xiaoqin; Li, Chunfu; Li, Jian; Zheng, Mincui; Mai, Huirong; Yang, Lihua; He, Yingyi; Xu, Honggui; et al. (Cancer medicine (Malden, MA), 2023)
Keywords: Acute myeloid leukemia; Adult; AML; ASXL1 mutation; Bone marrow; Chemotherapy; Child; Chromosomes; Cytogenetics; Genes; Hematopoietic stem cells; Humans; Karyotypes; Leukemia; Leukemia, Myeloid, Acute - genetics; Leukemia, Myeloid, Acute - therapy; Medical prognosis; Morphology; Multicenter Studies as Topic; Mutation; Nucleophosmin; Patients; Pediatrics; Polymerase chain reaction; Prognosis; Remission Induction; Repressor Proteins - genetics; Software; Stem cell transplantation; Transcription Factors - genetics; transplantation; China; AML; ASXL1 mutation; prognosis; pediatrics; transplantation